• Molecular NameFentanyl
  • SynonymFentanila [INN-Spanish]; fentanyl; Fentanyl citrate; Fentanylum [INN-Latin]
  • Weight336.479
  • Drugbank_IDDB00813
  • ACS_NO437-38-7
  • Show 2D model
  • LogP (experiment)4.05
  • LogP (predicted, AB/LogP v2.0)4.2
  • pka7.3, and 8.4
  • LogD (pH=7, predicted)3.09
  • Solubility (experiment)0.2 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.96
  • LogSw (predicted, AB/LogsW2.0)0.13
  • Sw (mg/ml) (predicted, ACD/Labs)0.14
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds6
  • TPSA23.55
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA synthetic primary μ-opioid agonist commonly used to treat chronic breakthrough pain and is commonly used in pre-procedures.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability1.0
  • Protein binding84.0
  • Volume of distribution (VD)4 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)Plasma:whole blood ratio, 1.0.
  • MetabollsmRapidly metabolised by by CYP3A in the liver. Two metabolites, norfentanyl and despropionylfentanyl, have been detected in plasma at concentrations similar to those of fentanyl.
  • Half life3.7 h (dose-dependent; also increased in the elderly and premature infants and during cardiopulmonary by-pass surgery).
  • ExcretionAbout 70% of a dose is excreted in the urine in 72 h, mostly as metabolites, with about 10 to 20% of a dose being excreted as unchanged drug in 48 h. About 9% of a dose is eliminated in the faeces. It crosses the placenta and small amounts may be found in breast milk.
  • Urinary Excretion8
  • Clerance13 ml/min/kg.
  • ToxicityThe estimated minimum lethal dose is 2 mg.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A